Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated:  7/13/2015
Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
mi
from
Wilkes-Barre, PA
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated: 7/13/2015
Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated:  7/13/2015
AnMed Cancer Center
mi
from
Anderson, SC
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated: 7/13/2015
AnMed Cancer Center
mi
from
Anderson, SC
Click here to add this to my saved trials
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated:  7/13/2015
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated: 7/13/2015
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated:  7/13/2015
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated: 7/13/2015
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated:  7/13/2015
Avera Cancer Institute
mi
from
Sioux Falls, SD
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated: 7/13/2015
Avera Cancer Institute
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated:  7/13/2015
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated: 7/13/2015
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated:  7/13/2015
Sanford Cancer Center at Sanford USD Medical Center
mi
from
Sioux Falls, SD
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated: 7/13/2015
Sanford Cancer Center at Sanford USD Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated:  7/13/2015
Fredericksburg Oncology, Incorporated
mi
from
Fredericksburg, VA
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated: 7/13/2015
Fredericksburg Oncology, Incorporated
mi
from
Fredericksburg, VA
Click here to add this to my saved trials
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated:  7/13/2015
Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated: 7/13/2015
Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Click here to add this to my saved trials
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated:  7/13/2015
Green Bay Oncology, Limited at St. Mary's Hospital
mi
from
Green Bay, WI
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated: 7/13/2015
Green Bay Oncology, Limited at St. Mary's Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated:  7/13/2015
St. Mary's Hospital Medical Center - Green Bay
mi
from
Green Bay, WI
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated: 7/13/2015
St. Mary's Hospital Medical Center - Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated:  7/13/2015
St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated: 7/13/2015
St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Click here to add this to my saved trials
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated:  7/13/2015
Bay Area Cancer Care Center at Bay Area Medical Center
mi
from
Marinette, WI
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated: 7/13/2015
Bay Area Cancer Care Center at Bay Area Medical Center
mi
from
Marinette, WI
Click here to add this to my saved trials
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated:  7/13/2015
Green Bay Oncology, Limited - Oconto Falls
mi
from
Oconto Falls, WI
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated: 7/13/2015
Green Bay Oncology, Limited - Oconto Falls
mi
from
Oconto Falls, WI
Click here to add this to my saved trials
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated:  7/13/2015
Green Bay Oncology, Limited - Sturgeon Bay
mi
from
Sturgeon Bay, WI
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum
Status: Enrolling
Updated: 7/13/2015
Green Bay Oncology, Limited - Sturgeon Bay
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Mobile Infirmary Medical Center
mi
from
Mobile, AL
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Mobile Infirmary Medical Center
mi
from
Mobile, AL
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Aurora Presbyterian Hospital
mi
from
Aurora, CO
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Aurora Presbyterian Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Boulder Community Hospital
mi
from
Boulder, CO
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Boulder Community Hospital
mi
from
Boulder, CO
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Penrose Cancer Center at Penrose Hospital
mi
from
Colorado Springs, CO
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Penrose Cancer Center at Penrose Hospital
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
St. Anthony Central Hospital
mi
from
Denver, CO
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
St. Anthony Central Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Porter Adventist Hospital
mi
from
Denver, CO
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Porter Adventist Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Presbyterian - St. Luke's Medical Center
mi
from
Denver, CO
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Presbyterian - St. Luke's Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
St. Joseph Hospital
mi
from
Denver, CO
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
St. Joseph Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Rose Medical Center
mi
from
Denver, CO
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Rose Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
CCOP - Colorado Cancer Research Program, Inc.
mi
from
Denver, CO
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
CCOP - Colorado Cancer Research Program, Inc.
mi
from
Denver, CO
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Swedish Medical Center
mi
from
Englewood, CO
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Swedish Medical Center
mi
from
Englewood, CO
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
mi
from
Grand Junction, CO
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
mi
from
Grand Junction, CO
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
North Colorado Medical Center
mi
from
Greeley, CO
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
North Colorado Medical Center
mi
from
Greeley, CO
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Sky Ridge Medical Center
mi
from
Lone Tree, CO
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Sky Ridge Medical Center
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Hope Cancer Care Center at Longmont United Hospital
mi
from
Longmont, CO
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Hope Cancer Care Center at Longmont United Hospital
mi
from
Longmont, CO
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
McKee Medical Center
mi
from
Loveland, CO
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
McKee Medical Center
mi
from
Loveland, CO
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
St. Mary - Corwin Regional Medical Center
mi
from
Pueblo, CO
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
St. Mary - Corwin Regional Medical Center
mi
from
Pueblo, CO
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
North Suburban Medical Center
mi
from
Thornton, CO
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
North Suburban Medical Center
mi
from
Thornton, CO
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Exempla Lutheran Medical Center
mi
from
Wheat Ridge, CO
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Exempla Lutheran Medical Center
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
MBCCOP - Medical College of Georgia Cancer Center
mi
from
Augusta, GA
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
MBCCOP - Medical College of Georgia Cancer Center
mi
from
Augusta, GA
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Tripler Army Medical Center
mi
from
Honolulu, HI
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Tripler Army Medical Center
mi
from
Honolulu, HI
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Rush-Copley Cancer Care Center
mi
from
Aurora, IL
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Rush-Copley Cancer Care Center
mi
from
Aurora, IL
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
St. Joseph Medical Center
mi
from
Bloomington, IL
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
St. Joseph Medical Center
mi
from
Bloomington, IL
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Graham Hospital
mi
from
Canton, IL
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Graham Hospital
mi
from
Canton, IL
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Memorial Hospital
mi
from
Carthage, IL
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Memorial Hospital
mi
from
Carthage, IL
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Eureka Community Hospital
mi
from
Eureka, IL
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Eureka Community Hospital
mi
from
Eureka, IL
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Galesburg Clinic, PC
mi
from
Galesburg, IL
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Galesburg Clinic, PC
mi
from
Galesburg, IL
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Galesburg Cottage Hospital
mi
from
Galesburg, IL
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Galesburg Cottage Hospital
mi
from
Galesburg, IL
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Mason District Hospital
mi
from
Havana, IL
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Mason District Hospital
mi
from
Havana, IL
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Hopedale Medical Complex
mi
from
Hopedale, IL
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Hopedale Medical Complex
mi
from
Hopedale, IL
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Joliet Oncology-Hematology Associates, Limited - West
mi
from
Joliet, IL
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Joliet Oncology-Hematology Associates, Limited - West
mi
from
Joliet, IL
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
Kewanee Hospital
mi
from
Kewanee, IL
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Kewanee Hospital
mi
from
Kewanee, IL
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated:  7/13/2015
McDonough District Hospital
mi
from
Macomb, IL
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
McDonough District Hospital
mi
from
Macomb, IL
Click here to add this to my saved trials